Skip to main content
. 2024 Jun 25;150(6):321. doi: 10.1007/s00432-024-05825-z

Table 2.

Objective response in the raw and propensity score-matched dataset

Nab-paclitaxelª n (%) Paclitaxelbn (%) P
Raw dataset (n = 78)
Objective response 39 (72.2) 11 (45.8) 0.025
Matched dataset (n = 58)
Objective response 30 (81.1) 10 (47.6) 0.008

NotesaPatients received nab-paclitaxel plus cisplatin or carboplatin. bPatients received paclitaxel plus cisplatin or carboplatin